Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1995-09-28
1999-08-17
Carlson, Karen C.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
530326, 530327, 530385, A61K 3700, C07K 708, C07K 750, C07K 14805
Patent
active
059393912
ABSTRACT:
Disclosed and claimed are methods for the isolation and use of stem cell inhibiting factors for regulating the abnormal stem cell cycle and for accelerating the post-chemotherapy peripheral blood cell recovery. Also disclosed and claimed are the inhibitors of stem cell proliferation.
REFERENCES:
patent: 4350683 (1982-09-01), Galfre et al.
patent: 4683194 (1987-07-01), Saiki et al.
patent: 5028588 (1991-07-01), Hoffman et al.
patent: 5239061 (1993-08-01), Fronticelli et al.
patent: 5449759 (1995-09-01), Hoffman et al.
Dunlop et al, Blood, vol. 79, No. 9, issued May 1, 1992, pp. 2221-2225 "Demonstration of Stem Cell Inhibition and Myeloprotective Effects of SCI/rhMIP1 alpha in vivo".
Davatelis et al, Journal of Experimental Medicine, vol. 157, issued Jun. 1988, pp. 1939-1944 "Cloning and Characterization of a cDNA for Murine Macrophage Inflammatory Protein (MIP), a Novel Monokine with Inflammatory and Chemokinetic Properties".
Hunkapillar et al, Methods in Enzymology, vol. 91, issued 1983, pp. 227-236 "Isolation of Microgram Quantities of Proteins from Polyacrylamide Gels for Amino Acid Sequence Analysis".
Lathe, Journal of Molecular Biology, vol. 183, issued 1985, pp. 1-12, "Synthetic Oligonucleotide Probes Deduced from Amino Acid Sequence Data. Theoretical and Practical Considerations".
Ohtsuka et al, Journal of Biological Chemistry, vol. 260, No. 5, issued Mar. 10, 1985, pp. 2605-2608 "An Alternative Approach to Deoxyoligonucleotides as Hybridization Probes by Insertion of Deoxyinosine at Ambiguous Codon Positions".
Kozlov, V.A., et al, Cell Tissue Kinet. (1987), 20 485-491, "The effect of haemopoietic stem cell proliferation on the humoral immune response in mice".
Eaves, C.J., et al., Blood, V. 78, No. 1 (Jul. 1), 1991:pp. 110-117 "Mechanisms That Regulate the Cell Cycle Status of Very Primitive Hematopoietic Cells in Long-Term Human Marrow Cultures. II. Analysis of Positive and Negative Regulators Produced by Stromal Cells Within the Adherent Layer."
Tejero, C., et al, Br. J. Cancer (1984), 50, 335-341 "The cellular specificity of haemopoietic stem cell proliferation regulators."
Graham, G.J., et al., Nature, V. 344, Mar. 29, 1990, pp. 442-444 "Identification and characterization of an inhibitor of haemopoietic stem cell proliferation."
Eaves, C.J., et al., Blood, vol. 78, No. 1 (Jul. 1), 1991:pp. 110-117 "Mechanisms That Regulate the Cell Cycle Status of Very Primitive Hematopoietic Cells in Long-Term Human marow Cultures. II. Analysis of Positive and Negative Regulators Produced by Stromal Cells Within the Adherent Layer."
Lord, B.I., et al, British Journal of Haematology, 1976, 34, 441 "An Inhibitor of Stem Cell Proliferation in Normal Bone Marrow."
Lord, B.I., et al., Blood Cells 6.581-593 (1980) "Sources of Haemopoietic Stem Cell Proliferation: Stimulators and Inhibitors."
Graham, G.J., et al, Nature vol. 344, Mar. 29, 1990 "Identification and Characterization of an Inhibitor of Haemopoietic Stem Cell Proliferation."
Wolpe, S.D., et al, J. Exp. Med. .COPYRGT. The Rockefeller University Press, vol. 167, Feb. 1988 570-581 "Macrophages Secrete A Novel Heparin-Binding protein With Inflammatory And Neutrophil Chemokinetic Properties."
Davatelis, G., et al, Science, vol. 243, Feb. 24, 1989, 1066-1068 "Macrophage Inflammatory Protein--1:A Prostaglandin-Independent Endogenous Pyrogen."
Broxmeyer, H.E., et al, J. Exp. Med. .COPYRGT. The Rockefeller University Press, vol. 170, Nov. 1989, 1583-1594 "Myelopoietic Enhancing Effects of Murine Macrophaage Inflammatory Proteins 1 and 2 on Colony Formation In Vitro By Murine And Human Bone Marrow Granulocyte/Macrophage Progenitor Cells."
Mundy, G.R., et al, Nature, vol. 275, Sep. 14, 1978 "Loss of Immunoreactivity in Long-Term Bone Marrow Culture."
Eaves, A.C., et al, CRC Critical Reviews in Oncolong/Hematology, vol. 7, Issue 2 (1987) 125-138 "Clinical Significance of Long-Term Cultures of Myeloid Blood Cells."
Eaves, A.C., et al, The Biology of Hematopoiesis, Editor: N Daniak, Alan R. Liss, Inc, NY, NY "The Therapeutic Potential of Long-Term CML Marrow Cultures."
Tsyrlova, I.G., et al, Lukemia: Advances in Biology and Therapy--Progress and Controversies, S326 (1988) "Improvement of Leukemic LTBMC Establishment by Using Specific Inhibitor of Hematopoietic Stem Cell Proliferation."
Till, J.E., et al, Radiation Research 14, 213-222 (1961) "A Direct Measurement of the Radiation Sensitivity of Normal Mouse Bone Marrow Cells."
Becker, A.J., et al, Blood, vol. 26, No. 3 (Sep.) 1965, 296-308 "The Effect of Differing Demands for Blood Cell Production on DNA Synthesis by Hemopoietic Colony-Forming Cells of Mice."
Byron, J.W., Nature, vol. 228 Dec. 1970, 1204 "Effect of Steroids on the Cycling of Haemopoietic Stem Cells."
Lord, B.I., et al, The Inhibitors of Hematopoiesis, vol. 162, pp. 227-239 (1987) "Inhibitor of Haemopoietic CFU-S Proliferation: Assays, Production Sources and Regulatory Mechanisms."
Lord, B.I., et al, Blood, vol. 79, No. 10 (May 15) 1992:pp.2605-2609 "Macrophage-Inflammatory Protein protects multipotent hematopoietic Cells From the Cytotoxic Effects of Hydroxyurea In Vivo."
Harrison, D.E., Blood, vol. 78, No. 5 (Sep. 2), 1991:pp.1237-1240 "Most Primitive Hematopoietic Stem Cells Are Stimulated To Cycle Rapidly After Treatment With 5-Fluorouracil."
Toksoz, D., et al, Blood, vol. 55, No. 6 (Jun.), 1980 "The Regulation of hemopoiesis in Long-term Bone Marrow Cultures. II. Stimulation and Inhibition of Stem Cell Proliferation."
Visser, Jan W.M., et al, Blood Cells (1988) 14:369-384 "Isolation of Spleen-Colony Forming Cells (CFU-s) Using Wheat Germ Agglutinin and Rhodamine 123 Labeling."
Whitlock, C., et al, Ann. Rev. Immunol. 1985 3:213-35 "In Vitro Analysis of Murine B-Cell Development."
Eaves, A.C., et al, Blood Cells (1988) 14:355-368 "Maintenance and proliferation Control of primitive Hemopoietic Progenitors in Long-Term Cultures of human Marrow Cells."
Phillips, G.L., et al, Bone Marrow Transplantation (1991), 8, 477-487 "Allogeneic Bone Marrow Transplantation Using Unrelated Donors: A Pilot Study of the Canadian Bone Marrow Transplant Group."
Ignat'Eva O Yu et al, Database Biosis, Biosciences Information Service, Phila., PA, XP002031939, Abstract; Byull Eksp Biol Med 98 (9) 1984 (Recd. 1985) 326-329 "Study of the Mechanism of Action of the Stem Cell Inhibition Factor on the Formation of Exogenous Hemopoietic Colonies in the Spleen of Mice".
Golovanova, T.A., et al, Ontogenez, 13 (3) 1982 243-250, "Influence of the Factor of Stem Cell Inhibition on the Formation of Hemopoietic Colonies"
Swanson, et al, Bio/Technology, vol. 10, pp. 557-559, May 1992, "Production of functional human hemoglobin in transgenic swine".
Kriegler, A.B., et al, Exp. Hematol., vol. 9, No. 1, pp. 11-21, Jan. 1981 "Identification of the "Factor" in Erythrocyte Lystes Which Enhances Colony Growth in Agar Cultures".
Moqattash, S., et al, Acta Haematol, 1994; 92:182-186, "Hemopoietic Recovery from AZT Toxicity with Recombinant Hemoglobin in a Murine Model of AIDS".
Petrov, Rem V., et al, Bioscience Reports, vol. 15, No. 1, 1995 "Myelopeptides: Bone Marrow Regulatory Mediators".
Shaeffer, J.R., The Journal of Biological Chemistry, vol. 269, No. 47, Issue of Nov. 25, 1994, pp. 29530-29536, "Heterogeneity in the Structure of the Ubiquitin Connugates of Human .alpha. Globin".
Karelin, A.A., et al, Peptides, vol. 16, No. 4, pp. 693-697, 1995 "Proteolytic Degradation of hemoglobin in Erythrocytes Leads to Biologically Active Peptides".
Mueller, S., et al, Blood, 1995 Nov. 15;86(10):1974--1974 "Purified Adult Hemoglobin Stimulates the Proliferation and Differentiation of Erythroid Progenitors".
Tsyrlova Irena
Wolpe Stephen D.
Carlson Karen C.
Pro-Neuron, Inc.
LandOfFree
Hemoglobin alpha chain peptide fragments useful for inhibiting s does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Hemoglobin alpha chain peptide fragments useful for inhibiting s, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hemoglobin alpha chain peptide fragments useful for inhibiting s will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-314839